Astellas Pharma (4503) Sustainable Meeting 2024 summary

Opening and context

• The meeting focused on the relationship between sustainability initiatives and enterprise value, with presentations from key executives and directors.

• Forward-looking statements were made, subject to risks and uncertainties, and simultaneous interpretation was provided.

Organizational health and innovation

• Organizational Health Goals (OHG) targeted innovation, talent, and leadership, with notable achievements in global regulatory submissions and leadership development.

• 13 regulatory submissions were completed in FY 2023, with approvals in 30 countries and launches in nine.

• The Next Generation Leadership Program developed 50 high-potential leaders, with four proposals advancing to business projects.

• Employee engagement scores declined to 69, prompting formation of a task force to address communication and change management.

Social impact and non-financial value

• Quantification of the Beauty & Health Program in Malaysia showed a $4.6 million social impact from a $1 million investment, mainly through early cancer detection.

• The program's impact included medical, psychological, and economic value, with primary benefits to patients and secondary benefits to families and institutions.

• Non-financial activities, especially human capital and governance, were analyzed for their link to market capitalization using data from 1,700 companies.

• Key indicators linked to market cap included percentage of female managers, employee satisfaction, and board diversity.